
The US Food and Drug Administration (FDA) has announced that it has approved Beyfortus (nirsevimab-alip) for the prevention of respiratory …

The US Food and Drug Administration (FDA) has announced that it has approved Jardiance (empagliflozin) and Synjardy (empagliflozin and metformin …

Children wait six and half years longer than adults to access new cancer drugs, according to a study from Dana-Farber/Boston …

The European Medicines Agency has relaxed some of its rules around the development of drugs in children, in order to …

Shire is launching a new clinical trial as part of its FDA submission for a potential ADHD treatment. The company …